UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 458

Sortiert nach

Targeting Bruton's tyrosine kinase in B cell malignancies

Nature reviews. Cancer, 2014-04, Vol.14 (4), p.219

2014

Link zum Volltext

Verfügbarkeit prüfen

Btk levels set the threshold for B-cell activation and negative selection of autoreactive B cells in mice

Blood, 2012-04, Vol.119 (16), p.3744-3756

2012

Link zum Volltext

Verfügbarkeit prüfen

Prostate cancer: Trends in incidence, survival and mortality in the Netherlands, 1989–2006

European journal of cancer (1990), 2010-07, Vol.46 (11), p.2077-2087

2010

Link zum Volltext

Verfügbarkeit prüfen

Restrained expansion of the recall germinal center response as biomarker of protection for influenza vaccination in mice

PloS one, 2019-11, Vol.14 (11), p.e0225063-e0225063

2019

Link zum Volltext

Verfügbarkeit prüfen

Aberrant B Cell Selection and Activation in Systemic Lupus Erythematosus

International Reviews of Immunology, 2013-08, Vol.32 (4), p.445-470

2013

Link zum Volltext

Verfügbarkeit prüfen

The role of B cell receptor stimulation in CLL pathogenesis

Current pharmaceutical design, 2012-08, Vol.18 (23), p.3335

2012

Link zum Volltext

Verfügbarkeit prüfen

Enhanced Expression of Bruton's Tyrosine Kinase in B Cells Drives Systemic Autoimmunity by Disrupting T Cell Homeostasis

The Journal of immunology (1950), 2016-07, Vol.197 (1), p.58-67

2016

Link zum Volltext

Verfügbarkeit prüfen

Variations in treatment policies and outcome for bladder cancer in the Netherlands

European journal of surgical oncology, 2010-09, Vol.36, p.S100-S107

2010

Link zum Volltext

Verfügbarkeit prüfen

The independent prognostic value of comorbidity among men aged < 75 years with localized prostate cancer: a population‐based study

BJU international, 2001-06, Vol.87 (9), p.821-826

2001

Link zum Volltext

Verfügbarkeit prüfen

Greater influence of age than co-morbidity on primary treatment and complications of prostate cancer patients: an in-depth population-based study

Prostate cancer and prostatic diseases, 2006-06, Vol.9 (2), p.179-184

2006

Link zum Volltext

Verfügbarkeit prüfen

DuoHexaBody-CD37 ® , a novel biparatopic CD37 antibody with enhanced Fc-mediated hexamerization as a potential therapy for B-cell malignancies

Blood cancer journal (New York), 2020-04, Vol.10 (3), p.30, Article 30

2020

Link zum Volltext

Verfügbarkeit prüfen

Basal Ca2+ signaling is particularly increased in mutated chronic lymphocytic leukemia

Leukemia, 2015-02, Vol.29 (2), p.321-328

2015

Link zum Volltext

Verfügbarkeit prüfen

POD-02.07 Development of a Risk-Based Decision Model for Prostate CAncer Gene 3 (PCA3) Usage

Urology (Ridgewood, N.J.), 2011, Vol.78 (3), p.S7-S7

2011

Link zum Volltext

Verfügbarkeit prüfen

UP-02.172 The Appropriateness of Active Surveillance and the Impact of Prostate Cancer Gene 3 (PCA3) in Low Risk Prostate Cancer: An Analysis of Expert Opinion

Urology (Ridgewood, N.J.), 2011, Vol.78 (3), p.S320-S320

2011

Link zum Volltext

Verfügbarkeit prüfen

Distinct and Overlapping Functions of TEC Kinase and BTK in B Cell Receptor Signaling

The Journal of immunology (1950), 2017-04, Vol.198 (8), p.3058-3068

2017

Link zum Volltext

Verfügbarkeit prüfen

Duration of Androgen Suppression in the Treatment of Prostate Cancer

The New England journal of medicine, 2009-06, Vol.360 (24), p.2516-2527

2009

Link zum Volltext

Verfügbarkeit prüfen

Basal Ca(2+) signaling is particularly increased in mutated chronic lymphocytic leukemia

Leukemia, 2015-02, Vol.29 (2), p.321-328

2015

Link zum Volltext

Verfügbarkeit prüfen

MP-13.08: Quality of Care Indicators for Muscle-Invasive Bladder Cancer

Urology (Ridgewood, N.J.), 2009, Vol.74 (4), p.S104-S105

2009

Link zum Volltext

Verfügbarkeit prüfen

Comorbidity in patients with prostate cancer and its relevance to treatment choice

BJU international, 1999-10, Vol.84 (6), p.652-656

1999

Link zum Volltext

Verfügbarkeit prüfen

Trends in incidence and mortality rates for prostate cancer before and after prostate-specific antigen introduction. A registry-based study in Southeastern Netherlands, 1971–1995

European journal of cancer (1990), 1998-04, Vol.34 (5), p.705-709

1998

Link zum Volltext

Verfügbarkeit prüfen

Bruton's tyrosine kinase mediated signaling enhances leukemogenesis in a mouse model for chronic lymphocytic leukemia

American journal of blood research, 2013-01, Vol.3 (1), p.71-83

2013

Link zum Volltext

Verfügbarkeit prüfen

Surrogate light chain expression beyond the pre-B cell stage promotes tolerance in a dose-dependent fashion

Journal of autoimmunity, 2015-02, Vol.57, p.30-41

2015

Link zum Volltext

Verfügbarkeit prüfen

Quality of life of Patients with newly diagnosed poor prognosis M1 prostate cancer undergoing orchiectomy without or with mitomycin C : Results from the EORTC phase-III trial 30893

European urology, 2000-05, Vol.37 (5), p.541-551

2000

Link zum Volltext

Verfügbarkeit prüfen

Using PSA to Guide Timing of Androgen Deprivation in Patients with T0–4 N0–2 M0 Prostate Cancer not Suitable for Local Curative Treatment (EORTC 30891)

European urology, 2008-05, Vol.53 (5), p.941-949

2008

Link zum Volltext

Verfügbarkeit prüfen

Tissue Polypeptide-Specific Antigen (TPS) Determinations before and during Intermittent Maximal Androgen Blockade in Patients with Metastatic Prostatic Carcinoma

European urology, 2003, Vol.43 (1), p.31-38

2003

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 458

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(405)
Mit Volltextzugriff
(425)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Targeting Bruton's tyrosine kinase in B cell malignancies

Btk levels set the threshold for B-cell activation and negative selection of autoreactive B cells in mice

Prostate cancer: Trends in incidence, survival and mortality in the Netherlands, 1989–2006

Restrained expansion of the recall germinal center response as biomarker of protection for influenza vaccination in mice

Aberrant B Cell Selection and Activation in Systemic Lupus Erythematosus

The role of B cell receptor stimulation in CLL pathogenesis

Enhanced Expression of Bruton's Tyrosine Kinase in B Cells Drives Systemic Autoimmunity by Disrupting T Cell Homeostasis

Variations in treatment policies and outcome for bladder cancer in the Netherlands

The independent prognostic value of comorbidity among men aged < 75 years with localized prostate cancer: a population‐based study

Greater influence of age than co-morbidity on primary treatment and complications of prostate cancer patients: an in-depth population-based study

DuoHexaBody-CD37 ® , a novel biparatopic CD37 antibody with enhanced Fc-mediated hexamerization as a potential therapy for B-cell malignancies

Basal Ca2+ signaling is particularly increased in mutated chronic lymphocytic leukemia

POD-02.07 Development of a Risk-Based Decision Model for Prostate CAncer Gene 3 (PCA3) Usage

UP-02.172 The Appropriateness of Active Surveillance and the Impact of Prostate Cancer Gene 3 (PCA3) in Low Risk Prostate Cancer: An Analysis of Expert Opinion

Distinct and Overlapping Functions of TEC Kinase and BTK in B Cell Receptor Signaling

Duration of Androgen Suppression in the Treatment of Prostate Cancer

Basal Ca(2+) signaling is particularly increased in mutated chronic lymphocytic leukemia

MP-13.08: Quality of Care Indicators for Muscle-Invasive Bladder Cancer

Comorbidity in patients with prostate cancer and its relevance to treatment choice

Trends in incidence and mortality rates for prostate cancer before and after prostate-specific antigen introduction. A registry-based study in Southeastern Netherlands, 1971–1995

Bruton's tyrosine kinase mediated signaling enhances leukemogenesis in a mouse model for chronic lymphocytic leukemia

Surrogate light chain expression beyond the pre-B cell stage promotes tolerance in a dose-dependent fashion

Quality of life of Patients with newly diagnosed poor prognosis M1 prostate cancer undergoing orchiectomy without or with mitomycin C : Results from the EORTC phase-III trial 30893

Using PSA to Guide Timing of Androgen Deprivation in Patients with T0–4 N0–2 M0 Prostate Cancer not Suitable for Local Curative Treatment (EORTC 30891)

Tissue Polypeptide-Specific Antigen (TPS) Determinations before and during Intermittent Maximal Androgen Blockade in Patients with Metastatic Prostatic Carcinoma

Suchergebnisse filtern